Verition Fund Management LLC
- SEC CIK
- 0001454027
- Latest filing
- Aug 14, 2026
The latest 13F from Verition Fund Management LLC covers Q2 2026 (filed Aug 14, 2026): 1,442 long positions worth $14.2B. The top 10 holdings make up 25.3% of the portfolio, and the largest is iShares Core S&P 500 ETF at 9.9%. Livermore has 27 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 368
- Est. +$1.91B
- Added
- 448
- Est. +$4.17B
- Reduced
- 444
- Est. −$1.92B
- Sold out
- 520
- Est. −$1.34B
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $14.2B
- +$3.91B (+37.9%) vs. prior quarter
- Positions
- 1,442
- −152 vs. prior quarter
- Top 10 concentration
- 25.3%
- Top 10 as share of value
- Turnover
- 26.5%
- Q2 2026, one quarter
- Average holding period
- 11.1 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $19.8B (Q4 2024)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 14, 2026Amended | 1,442 | $14.2B | iShares Core S&P 500 ETFSPYWBD | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 1,594 | $10.3B | SPYiShares Core S&P 500 ETFWBD | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 13, 2026 | 2,750 | $18.5B | iShares Core S&P 500 ETFSPYNVDA | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 2,883 | $17.5B | iShares Core S&P 500 ETFNVDASPY | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 2,861 | $17.4B | iShares Iboxx $ Investment Grade Corporate Bond ETFNVDASPY | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 2,615 | $17.4B | iShares Core S&P 500 ETFNVDAAMZN | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 2,538 | $19.8B | iShares Core S&P 500 ETFNVDAMSFT | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 2,436 | $14.8B | NVDASPYPWSC | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 2,293 | $12.9B | MSFTNVDAAMZN | vs. Q1 2024 | SEC |
| Q1 2024 | May 14, 2024 | 2,132 | $10.5B | SPYNVDABRK.B | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 1,838 | $9.83B | SPYNVDAAAPL | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 1,942 | $7.48B | Nisource Inc.ATVISPY | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 1,872 | $6.41B | SPYDexcom IncGOOGL | vs. Q1 2023 | SEC |
| Q1 2023 | May 15, 2023 | 1,939 | $6.27B | HZNPMongoDB, Inc.Dexcom Inc | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 14, 2023 | 1,647 | $5.14B | Dexcom IncONBMongoDB, Inc. | vs. Q3 2022 | SEC |
| Q3 2022 | Jan 18, 2023Amended | 2,410 | $7.27B | AVLRPCGATVI | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 30, 2022Amended | 2,180 | $4.62B | iShares Iboxx $ Investment Grade Corporate Bond ETFONBMongoDB, Inc. | vs. Q1 2022 | SEC |
| Q1 2022 | Jun 2, 2022Amended | 1,883 | $5.21B | Dexcom IncATVIAAPL | vs. Q4 2021 | SEC |
| Q4 2021 | May 3, 2022Amended | 1,806 | $7.94B | METAAMZNDIS | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 1,591 | $6.59B | AMZNBABIDU | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021 | 1,711 | $6.81B | AMZNMETAMSFT | vs. Q1 2021 | SEC |
| Q1 2021 | May 18, 2021 | 1,397 | $5.50B | AMZNBAMETA | – | SEC |
13D and 13G filings
Companies where Verition Fund Management LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
2 companies, largest stake first.
| Company | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| GSHRGesher Acquisition Corp. II | 13G/A | 7.20%1.10M shares | −1.30 ppfrom 8.50% | May 15, 20252 filings | Aug 14, 2025 | SEC |
| MKLYUMcKinley Acquisition Corp | 13G | 6.40%1.10M shares | New | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
Latest filings
12 filings on file made by Verition Fund Management LLC or listing it as a reporting person, newest first.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| MKLYMcKinley Acquisition Corp | May 15, 20268:52 AM ET | 13G/A | 3.80%685.3K shares | –Below 5% | Mar 31, 2026 | SEC |
| KOYNCSLM Digital Asset Acquisition Corp III, Ltd | May 15, 20268:52 AM ET | 13G/A | 2.90%700.0K shares | −2.20 ppfrom 5.10%Below 5% | Mar 31, 2026 | SEC |
| KOYNCSLM Digital Asset Acquisition Corp III, Ltd | Feb 13, 20264:34 PM ET | 13G | 5.10%1.22M shares | New | Dec 31, 2025 | SEC |
| TVAIUThayer Ventures Acquisition Corp II | Nov 14, 20259:31 AM ET | 13G/A | 3.30%680.3K shares | −1.73 ppfrom 5.03%Below 5% | Sep 30, 2025 | SEC |
| MKLYUMcKinley Acquisition Corp | Nov 14, 20259:30 AM ET | 13G | 6.40%1.10M shares | New | Sep 30, 2025 | SEC |
| TVAIUThayer Ventures Acquisition Corp II | Aug 14, 20258:55 AM ET | 13G | 5.03%1.03M shares | New | Jun 30, 2025 | SEC |
| GSHRGesher Acquisition Corp. II | Aug 14, 20258:53 AM ET | 13G/A | 7.20%1.10M shares | −1.30 ppfrom 8.50% | Jun 30, 2025 | SEC |
| GSHRGesher Acquisition Corp. II | May 15, 202510:54 AM ET | 13G | 8.50%1.30M shares | New | Mar 31, 2025 | SEC |
| PRAXPraxis Precision Medicines, Inc. | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| LRMRLarimar Therapeutics, Inc. | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| PRAXPraxis Precision Medicines, Inc. | Feb 14, 2024 | 13GOld format | – | New | – | SEC |
| LRMRLarimar Therapeutics, Inc. | Feb 14, 2024 | 13GOld format | – | New | – | SEC |